Literature DB >> 11274695

Chemotherapy for eye cancer.

M W Wilson1, G Czechonska, P T Finger, A Rausen, M E Hooper, B G Haik.   

Abstract

Chemotherapy has been used to treat a multitude of eye cancers. We attempted to review the role of chemotherapy in the treatment of ocular, adnexal, and orbital malignancies by conducting an extensive search of the medical literature. Unfortunately, the published reports typically contain few patients with limited follow-up, precluding definitive recommendations. For most eye cancers, multicenter trials will offer the potential to gather the numbers of patients required to determine the clinical utility of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274695     DOI: 10.1016/s0039-6257(00)00210-1

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  16 in total

1.  Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

2.  Vesicular stomatitis virus induces apoptosis in the Wong-Kilbourne derivative of the Chang conjunctival cell line.

Authors:  Eva Gallyas; György Seprényi; Eniko Sonkoly; Yvette Mándi; Lajos Kemény; Klára Megyeri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-19       Impact factor: 3.117

3.  Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia.

Authors:  P T Finger; D Reichstein
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

4.  Thermochemotherapy in hereditary retinoblastoma.

Authors:  A O Schueler; C Jurklies; H Heimann; R Wieland; W Havers; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 5.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

6.  Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.

Authors:  Madhavi Kurli; Paul T Finger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-07       Impact factor: 3.117

7.  "Finger-tip" cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

8.  Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.

Authors:  Joo Young Shin; Jeong Hun Kim; Young Suk Yu; Sang In Khwarg; Ho Kyung Choung; Hee Young Shin; Hyo Seop Ahn
Journal:  Korean J Ophthalmol       Date:  2010-08-03

9.  NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.

Authors:  Ashwin Nair; Paul Thevenot; Wenjing Hu; Liping Tang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

10.  Three dimensional ultrasound of retinoblastoma: initial experience.

Authors:  P T Finger; A Khoobehi; M R Ponce-Contreras; D Della Rocca; J P S Garcia
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.